Skip to main content
Figure 5 | BMC Cancer

Figure 5

From: Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

Figure 5

Activation of STAT3 in response to paclitaxel treatment in HEY cells. HEY cells were treated with paclitaxel (1 ng/ml) for 6, 12, 24, 48 and 72 hours. Cell lysates were prepared and Western blot was performed as described in the Methods. Total protein loading was determined by probing the membranes for GAPDH. Results are representative of three independent experiments.

Back to article page